Ligand validation:6NC9

OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLB is a Ligand Of Interest in 6NC9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NC9_OLB_A_508	30%	57%	0.183	0.866	0.86	0.81	1	1	0	0	88%	0.88
6NC9_OLB_A_506	29%	52%	0.132	0.832	0.93	0.94	2	1	0	0	76%	0.76
6NC9_OLB_A_507	27%	55%	0.178	0.843	0.84	0.9	2	-	0	0	88%	0.88
6NC9_OLB_A_504	18%	55%	0.205	0.826	0.81	0.91	1	1	1	0	80%	0.8
6NC9_OLB_A_502	13%	55%	0.194	0.751	0.85	0.87	1	1	0	0	88%	0.88
6NC9_OLB_A_505	9%	50%	0.207	0.744	0.95	0.97	2	1	0	0	72%	0.72
6NC9_OLB_A_503	6%	52%	0.212	0.684	0.93	0.94	2	1	1	0	76%	0.76
5T77_OLB_A_517	14%	54%	0.207	0.777	0.86	0.92	2	1	0	0	88%	0.88
6NC6_OLB_A_506	8%	51%	0.327	0.861	0.96	0.95	2	1	0	0	72%	0.72
5LX9_OLB_A_409	49%	93%	0.17	0.917	0.19	0.3	-	-	1	0	100%	0.64
4KPP_OLB_A_502	41%	46%	0.17	0.892	1.07	1.02	2	1	0	0	96%	0.96
6XLP_OLB_A_616	34%	61%	0.182	0.908	0.8	0.69	-	-	1	0	76%	0.76
5IUB_OLB_A_2421	34%	53%	0.166	0.898	0.93	0.89	2	1	0	0	72%	0.72
7AVN_OLB_B_314	34%	39%	0.105	0.863	1.2	1.18	1	1	3	0	56%	0.56

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.